A pilot trial of irinotecan, 5-fluorouracil, and leucovorin [folinic acid] combined with the anti-angiogenesis agent tetrathiomolybdate in metastatic colorectal carcinoma (UMCC 0075)
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Tetrathiomolybdate (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2005 New trial record.